PREMIER CONSULTING
Live / Registered — Registered (as of 02 Jan 2024)
What this means for you
Registered since 02 Jan 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jan 2030: the §8 declaration of use).
Record
- Serial number
- 97088470
- Registration number
- 7264370
- Mark type
- Word mark
- Filed
- 22 Oct 2021
- Registered
- 02 Jan 2024
- Next maintenance filing
- §8 declaration of use, due by 02 Jan 2030 (grace period to 02 Jul 2030)
- Attorney of record
- ROBERT P. PARKER
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Pharmaceutical products development; Pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development and medical device and diagnostic research and development
Owner
- Premier Research International LLC, Morrisville, NC, US
- Premier Research International LLC, Morrisville, NC, US
Prior registrations
Board proceedings on this mark
- Ex Parte Appeal No. 97088470 — Premier Research International LLC, filed 08 May 2023 (Terminated)
Prosecution history
- 02 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jan 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 09 May 2023 — EXPARTE APPEAL TERMINATED
- 09 May 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 08 May 2023 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 08 May 2023 — USE AMENDMENT ACCEPTED
- 08 May 2023 — EX PARTE APPEAL-INSTITUTED
- 08 May 2023 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 08 May 2023 — EXPARTE APPEAL RECEIVED AT TTAB
- 05 May 2023 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 06 May 2023 — AMENDMENT TO USE PROCESSING COMPLETE
- 06 May 2023 — USE AMENDMENT FILED
- 05 May 2023 — TEAS AMENDMENT OF USE RECEIVED
- 08 Nov 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 08 Nov 2022 — FINAL REFUSAL E-MAILED